Lv1
20 积分 2025-05-29 加入
A new PK equivalence test for a bridging study
8天前
已完结
Tuberculosis and immigration: the answers that epidemiology can provide (and society is waiting for)
2个月前
已关闭
[Tuberculosis and immigration: the answers that epidemiology can provide (and society is waiting for)]
2个月前
已关闭
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trial
2个月前
已完结
Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study
2个月前
已完结
Rifabutin triple therapy for first‐line and rescue treatment of Helicobacter pylori infection: A systematic review and meta‐analysis
2个月前
已完结
Using Partial Area for Evaluation of Bioavailability and Bioequivalence
2个月前
已完结
A Simulation Study of the Comparative Performance of Partial Area under the Curve (pAUC) and Partial Area under the Effect Curve (pAUEC) Metrics in Crossover Versus Replicated Crossover Bioequivalence Studies for Concerta and Ritalin LA
2个月前
已完结
Use of Partial Area Under the Curve in Bioavailability or Bioequivalence Assessments: A Regulatory Perspective
2个月前
已完结
A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence Assessments
2个月前
已完结
皖公网安备34019202002308
